AKBA vs UPST · rev $102.7M vs P/E 74, rev $672.9M
Akebia Ther (AKBA) versus Upstart Holdings Inc (UPST) — a side-by-side from cached financials, not a winner call.
Akebia Ther (AKBA) is a drug manufacturers - specialty & generic company listed on US.
Upstart Holdings Inc (UPST) is a credit services company listed on NASDAQ.
Latest reported AKBA revenue for 2026-06-30 was $102.7M. Net income was -$18.0M. Revenue was up 91.8% from 2026-03-31 to 2026-06-30. AKBA currently screens at market cap $260.1M.
Latest reported UPST revenue for 2026-06-30 was $672.9M. Net income was $9.9M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
AKBA currently screens at market cap $260.1M. UPST currently screens at market cap $2.92B and trailing P/E 74.3.
Not investment advice. Open the AKBA and UPST stock pages for the full models.
Not investment advice.